Clinical reversal of multidrug resistance

Cancer Treat Res. 1994:73:149-65. doi: 10.1007/978-1-4615-2632-2_8.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Review

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / physiology
  • Antineoplastic Agents / pharmacology
  • Biological Transport, Active / drug effects
  • Clinical Trials as Topic
  • Cyclosporine / adverse effects
  • Cyclosporine / pharmacology
  • Cyclosporine / therapeutic use*
  • Drug Resistance, Multiple*
  • Etoposide / adverse effects
  • Etoposide / therapeutic use
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Pharmaceutical Preparations / metabolism
  • Verapamil / pharmacology
  • Verapamil / therapeutic use*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents
  • Neoplasm Proteins
  • Pharmaceutical Preparations
  • Etoposide
  • Cyclosporine
  • Verapamil
  • Paclitaxel